Found: 23
Select item for more details and to access through your institution.
Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa576
- By:
- Publication type:
- Article
Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz438
- By:
- Publication type:
- Article
259. Racial Differences in Clinical Phenotype and Hospitalization of Blastomycosis Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S144, doi. 10.1093/ofid/ofz360.334
- By:
- Publication type:
- Article
Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 12, p. N.PAG, doi. 10.1093/ofid/ofy316
- By:
- Publication type:
- Article
Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 2, p. 173, doi. 10.1093/jpids/piz001
- By:
- Publication type:
- Article
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 12, p. 2442, doi. 10.3201/eid2912.231070
- By:
- Publication type:
- Article
Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017-2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
- Published in:
- BMC Infectious Diseases, 2024, p. 1, doi. 10.1186/s12879-024-09108-3
- By:
- Publication type:
- Article
Effect of Statin Use on Influenza Vaccine Effectiveness.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72081-z
- By:
- Publication type:
- Article
Analysis and Incidence Calculation of Snowmobile Injuries Identified in a Rural Wisconsin Health Care System Over Five Years.
- Published in:
- Wisconsin Medical Journal, 2022, v. 121, n. 4, p. 256
- By:
- Publication type:
- Article
Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 1, p. 100, doi. 10.1093/jpids/piad109
- By:
- Publication type:
- Article
Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013.
- Published in:
- Clinical Infectious Diseases, 2016, v. 62, n. 4, p. 448, doi. 10.1093/cid/civ952
- By:
- Publication type:
- Article
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S271, doi. 10.1093/cid/ciac472
- By:
- Publication type:
- Article
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022.
- Published in:
- Influenza & Other Respiratory Viruses, 2023, v. 17, n. 3, p. 1, doi. 10.1111/irv.13104
- By:
- Publication type:
- Article
Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 673, doi. 10.1111/irv.12973
- By:
- Publication type:
- Article
mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 4, p. 607, doi. 10.1111/irv.12970
- By:
- Publication type:
- Article
Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 6, p. 697, doi. 10.1111/irv.12880
- By:
- Publication type:
- Article
Validation of self‐reported influenza vaccination in the current and prior season.
- Published in:
- Influenza & Other Respiratory Viruses, 2018, v. 12, n. 6, p. 808, doi. 10.1111/irv.12593
- By:
- Publication type:
- Article
School absenteeism among school-aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012-2013 through 2014-2015.
- Published in:
- Influenza & Other Respiratory Viruses, 2017, v. 11, n. 3, p. 220, doi. 10.1111/irv.12440
- By:
- Publication type:
- Article
Association of Tdap Vaccination With Acute Events and Adverse Birth Outcomes Among Pregnant Women With Prior Tetanus-Containing Immunizations.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of Immune Priming, Vaccination, and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
- Published in:
- 2021
- By:
- Publication type:
- journal article